Zanubrutinib As Upfront Treatment in De-Novo B-Cell Prolymphocytic Leukemia: The Case of Two Elderlies. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025061. https://doi.org/10.4084/MJHID.2025.061.